BIODESIX INC — Director's Dealing 2025

May 20, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2025-05-16

Reporting Person: SCHULER JACK W (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-16	Common Stock	P	4000000	$0.2675	Acquired	20194935	Indirect
2025-05-19	Common Stock	P	723239	$0.341	Acquired	20918174	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15000000	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.2215 to $0.3397, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: Reported amounts have been adjusted to reflect the transfer of 15,000,000 shares previously held by the Jack W. Schuler Living Trust to the Jack W. Schuler 2025 GRAT on January 29, 2025, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

F3: Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.

F4: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.2997 to $0.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F5: Jack W. Schuler is the sole trustee of the Jack W. Schuler 2025 GRAT.